Sökning: WFRF:(Secnik Juraj) >
Secondary Stroke Pr...
Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders
-
- Zupanic, Eva (författare)
- Karolinska Institutet,University of Ljubljana,University Medical Centre Ljubljana
-
- Kramberger, Milica G. (författare)
- Karolinska Institutet,University of Ljubljana,University Medical Centre Ljubljana
-
- von Euler, Mia, 1967- (författare)
- Karolinska Institutet,Karolinska University Hospital
-
visa fler...
-
- Norrving, Bo (författare)
- Lund University,Lunds universitet,Klinisk strokeforskning,Forskargrupper vid Lunds universitet,Stroke policy och kvalitetsregisterforskning,Clinical Stroke Research Group,Lund University Research Groups,Stroke policy and quality register research
-
- Winblad, Bengt (författare)
- Karolinska Institutet,Karolinska University Hospital
-
- Secnik, Juraj (författare)
- Karolinska Institutet
-
- Fastbom, Johan (författare)
- Stockholm University,Karolinska Institutet,Stockholms universitet,Centrum för forskning om äldre och åldrande (ARC), (tills m KI)
-
- Eriksdotter, Maria (författare)
- Karolinska Institutet,Karolinska University Hospital
-
- Garcia-Ptacek, Sara (författare)
- Karolinska Institutet,Stockholm South General Hospital
-
visa färre...
-
(creator_code:org_t)
- Amsterdam : IOS Press, 2020
- 2020
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - Amsterdam : IOS Press. - 1387-2877 .- 1875-8908. ; 73:3, s. 1013-1021
- Relaterad länk:
-
https://doi.org/10.3...
-
visa fler...
-
http://dx.doi.org/10... (free)
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
https://urn.kb.se/re...
-
http://kipublication...
-
https://lup.lub.lu.s...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Recurrent ischemic stroke (IS) increases the risk of cognitive decline. To lower the risk of recurrent IS, secondary prevention is essential.OBJECTIVE: Our aim was to compare post-discharge secondary IS prevention and its maintenance up to 3 years after first IS in patients with and without Alzheimer's disease and other dementia disorders.METHODS: Prospective open-cohort study 2007-2014 from the Swedish national dementia registry (SveDem) and the Swedish national stroke registry (Riksstroke). Patients with dementia who experienced an IS (n = 1410; 332 [23.5%] with Alzheimer's disease) were compared with matched non-dementia IS patients (n = 7150). We analyzed antiplatelet, anticoagulant, blood pressure lowering, and statin treatment as planned medication initiation at discharge and actual dispensation of medications at first, second, and third year post-stroke.RESULTS: At discharge, planned initiation of medication was higher in patients with dementia compared to non-dementia patients for antiplatelets (OR with 95% CI for fully adjusted models 1.23 [1.02-1.48]) and lower for blood pressure lowering medication (BPLM; 0.57 [0.49-0.67]), statins (0.57 [0.50-0.66]), and anticoagulants (in patients with atrial fibrillation - AF; 0.41 [0.32-0.53]). When analysis for antiplatelets was stratified according to the presence of AF, ORs for receiving antiplatelets remained significant only in the presence of AF (in the presence of AF 1.56 [1.21-2.01], in patients without AF 0.99 [0.75-1.33]). Similar trends were observed in 1st, 2nd, and 3rd year post-stroke.CONCLUSIONS: Dementia was a predictor of lower statin and BPLM use. Patients with dementia and AF were more likely to be prescribed antiplatelets and less likely to receive anticoagulants.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Geriatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Geriatrics (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Annan medicin och hälsovetenskap -- Gerontologi, medicinsk/hälsovetenskaplig inriktning (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Other Medical and Health Sciences -- Gerontology, specialising in Medical and Health Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- Alzheimer’s disease
- anticoagulants
- antihypertensive agents
- cohort studies
- dementia
- hydroxymethylglutaryl-CoA reductase inhibitors
- ischemic stroke
- platelet aggregation inhibitors
- secondary prevention
- Alzheimer’s disease
- anticoagulants
- antihypertensive agents
- cohort studies
- dementia
- hydroxymethylglutaryl-CoA reductase inhibitors
- ischemic stroke
- platelet aggregation inhibitors
- secondary prevention
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Zupanic, Eva
-
Kramberger, Mili ...
-
von Euler, Mia, ...
-
Norrving, Bo
-
Winblad, Bengt
-
Secnik, Juraj
-
visa fler...
-
Fastbom, Johan
-
Eriksdotter, Mar ...
-
Garcia-Ptacek, S ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Geriatrik
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Annan medicin oc ...
-
och Gerontologi medi ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Örebro universitet
-
Stockholms universitet
-
Karolinska Institutet
-
Lunds universitet